Barbara Colombi

Biologo

Pansarasa O, Castagna L, Colombi B, Vecchiet J, Felzani G, Marzatico F. Age and sex differences in human skeletal muscle: role of reactive oxygen species. Free Radic Res. 2000 Sep;33(3): 287-93.

Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, De Simone L, Coltorti F, Bloise R, Keegan R, Cruz Filho FES, Vignati G, Benatar A, Delogu A. Clinical and Molecular Characterization of Patients with Catecholominergic Polymorphic Ventricular Tachycardia. Circulation 2002;106: 69-74.

Priori SG, Bloise R, Memmi M, Colombi B, Napolitano C, Coltorti F, Gasparini M, Keegan R, Cruz Filho FES, Drago F, Vignati G, Benatar A, De Simone L, DeLogu A. RYR2 and CASQ2 Mutations in Patients suffering from Catecholaminergic Polymorphic Ventricular Tachycardia. Circulation 2002 Jul 2;106(1): 69-74.

Cerrone M, Colombi B, Santoro M, Raffaele di Barletta M, Scelsi M, Villani L, Napolitano C, Priori SG. Bidirectional Ventricular Tachycardia and Fibrillation Elicited in a Knock-In Mouse Model Carrier of a Mutation in the Cardiac Ryanodine Receptor (RyR2). Circ Res. 2005; 96:e77-82.

Liu N, Colombi B, Memmi M, Zissimopoulos S, Rizzi N, Negri S, Imbriani M, Napolitano C, Lai FA, Priori SG. Arrhythmogenesis in Catecholaminergic Polymorphic Ventricular Tachycardia: insights from a RyR2 R4496C knock-in mouse model. Circ Res 2006; 99:292-298.

Liu N, Colombi B, Raytcheva-Buono EV, Bloise R, Priori SG. Catecholaminergic Polymorphic Ventricular Tachycardia. Herz. 2007;32(3): 212-217.

Rizzi N, Liu N, Napolitano C, Nori A, Turcato F, Colombi B, Bicciato S, Arcelli D, Spedito A, Scelsi M, Villani L, Esposito G, Boncompagni S, Protasi F, Volpe P, Priori SG. Unexpected structural and functional consequences of the R33Q homozygous mutation in cardiac calsequestrin: a complex arrhythmogenic cascade in a knock in mouse model. Circ Res. 2008 Aug 1;103(3): 298-306.

Fernández-Velasco M, Rueda A, Rizzi N, Benitah JP, Colombi B, Napolitano C, Priori SG, Richard S, Gómez AM  Increased Ca2+ Sensitivity of the Ryanodine Receptor Mutant RyR2R4496C Underlies Catecholaminergic Polymorphic Ventricular Tachycardia. Circ Res. 2008 Dec 18.

Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia.Liu N, Ruan Y, Denegri M, Bachetti T, Li Y, Colombi B, Napolitano C, Coetzee WA, Priori SG. J Mol Cell Cardiol. 2010 Oct 8.